Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lyell Immunopharma Inc (NQ: LYEL ) 1.150 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Lyell Immunopharma Inc < Previous 1 2 3 4 Next > GSK Walks Away From T-Cell Therapy Pact With Lyell Citing Strategic Actions October 25, 2022 Via Benzinga Analyst Sees A Leader In Solid Tumor Cell Therapy In This Stock October 17, 2022 Via Benzinga 5 Value Stocks In The Healthcare Sector October 17, 2022 What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022 October 17, 2022 Upgrades Via Benzinga The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal July 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... Via Benzinga Exposures COVID-19 Lyell Immunopharma Announces FDA Clearance of its IND for LYL845, a TIL Product Candidate Enhanced with its Novel Epigenetic Reprogramming Technology for Solid Tumors October 06, 2022 From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma to Present Preclinical Data Highlighting New T-Cell Reprogramming Technologies and its Growing Pipeline at 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting October 05, 2022 From Lyell Immunopharma, Inc Via GlobeNewswire Lyell Immunopharma Announces the Appointment of Rahsaan Thompson as Chief Legal Officer September 28, 2022 From Lyell Immunopharma, Inc Via GlobeNewswire 5 Value Stocks In The Healthcare Sector September 12, 2022 What are Value Stocks? Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session August 26, 2022 Via Benzinga Why U.S. Stocks Are Trading Lower; AZZ Earnings And More July 11, 2022 U.S. stocks traded lower this morning as investors digested the recent jobs report for the month of June. Via Benzinga Biotech ETF Tops in June: 5 Stocks That Outperform June 30, 2022 Although most of the stocks in BBC’s portfolio have delivered strong returns this year so far, a few have gained more than 45%. Via Talk Markets 89 Biggest Movers From Friday June 21, 2022 Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday May 17, 2022 On Tuesday, 123 stocks made new 52-week lows. Via Benzinga FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors January 24, 2022 The FDA has cleared Lyell Immunopharma Inc's (NASDAQ: LYEL) Investigational New Drug (IND) application to initiate a Phase 1 trial for LYL132 in solid tumors.... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday January 05, 2022 Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a... Via Benzinga The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx December 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 11, 2021 Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares increased by 92.43% to $35.1 during Monday's regular session. Trading volume for this security as of 12:30 EST is... Via Benzinga 54 Biggest Movers From Friday October 04, 2021 Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc.... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session September 28, 2021 Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 35.02% to $7.22 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is... Via Benzinga The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data September 21, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold September 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session September 14, 2021 Gainers Progenity (NASDAQ:PROG) shares increased by 17.0% to $1.1 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 40.5... Via Benzinga 72 Biggest Movers From Yesterday September 14, 2021 Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session September 13, 2021 Gainers Itamar Medical (NASDAQ:ITMR) shares increased by 46.58% to $30.25 during Monday's regular session. Trading volume for Itamar Medical's stock is 2.6 million... Via Benzinga 45 Stocks Moving In Monday's Mid-Day Session September 13, 2021 Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)... Via Benzinga 45 Stocks Moving In Tuesday's Mid-Day Session September 07, 2021 Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently... Via Benzinga The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod September 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs July 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts July 27, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.